Educational Intervention on Oral Anticancer Agents for Community Pharmacists
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMonash University Malaysia
About this trial
The overall aim of this study is to develop and test the feasibility and acceptability of an educational intervention for community pharmacists to provide support to patients receiving oral anticancer agents (OAAs) in the community. This pilot randomized controlled trial aims to evaluate the feasibility, acceptability, and preliminary effect of an educational intervention on the knowledge and confidence in managing OAAs among community pharmacists in Malaysia.
PRIMARY OBJECTIVE • To evaluate the feasibility and acceptability of the educational intervention on OAAs among community pharmacists.
SECONDARY OBJECTIVE
• To obtain preliminary data on the effect of the educational intervention to improve community pharmacists' knowledge and confidence in managing OAAs.
Participants will be randomly assigned to either the intervention group or control group in a 1:1 ratio using block randomization. After enrolling, participants will be asked to complete a baseline survey assessing their knowledge and confidence in managing OAAs. Immediately after completing the intervention and 4 weeks after the intervention, participants in the intervention group and control group will repeat the same questionnaire to assess changes in their knowledge and confidence.
Results of this pilot study will inform the design of a larger study to test whether this intervention improves community pharmacists' knowledge and confidence. This research may help better prepare community pharmacists to provide high-quality care to patients receiving OAAs.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Currently a registered pharmacist working in community pharmacy in Malaysia
Provided written informed consent
Ability to read and understand English
Basic digital literacy and ability to use computer/tablet devices
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Educational intervention on managing oral anticancer agents in community pharmacy setting
Other interventionParticipants attend an educational program on managing oral anticancer agents in community pharmacy setting.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Intervention GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Feasibility indicators composite
Composite measure of five feasibility indicators: 1. Recruitment: proportion of pharmacists who consent to participate in the study out of those who were approached and were eligible for participation. Time required to recruit target number of participants; 2. Retention rate: proportion of participants who completed each outcome assessment at three measurement timepoints; 3. Adherence rate: proportion of intervention group pharmacists who attended and completed the full educational program; 4. Attrition rate: proportion of participants who dropped out of the study after enrolment among all participants. Reasons for dropout will also be recorded.
Time frame
Baseline to 4-week follow up2
Acceptability of the intervention
Acceptability of the intervention will be measured by a satisfaction questionnaire developed by the research team. The questionnaire included 14 items and 2 optional open-ended questions. The questionnaire explored participants' perceptions of the usefulness and satisfaction with the intervention. The items will be evaluated using a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = uncertainty, 4 = agree, 5 = strongly agree), with higher score indicating better acceptability.
Time frame
Immediately post-interventionSecondary outcomes
1
Knowledge of oral anticancer agents
Measured using a questionnaire which assessed the knowledge and confidence regarding managing oral anticancer agents. The questionnaire consists of 3 items on self-perceived knowledge and 10 items on objective knowledge of OAAs. The self-perceived knowledge will be evaluated using a 5-point Likert scale (1 = very poor, 2 = poor, 3 = acceptable, 4 = good, 5 = very good). The total score will range from 3 to 15, with higher score indicating higher level of perceived knowledge. The objective knowledge questions will be scored on a numeric scale ranging from 0 to 10, where higher scores indicate better knowledge of OAAs.
Time frame
Baseline (T1), immediately post-intervention (T2), and 4 weeks post-intervention (T3)2
Confidence in managing oral anticancer agents
Measured using a questionnaire which assessed the knowledge and confidence regarding managing oral anticancer agents. The questionnaire consists of 4 items on the self-reported confidence to manage OAAs. The items will be evaluated using a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). The total score will range from 4 to 20, where higher score indicating higher confidence.
Time frame
Baseline (T1), immediately post-intervention (T2), and 4 weeks post-intervention (T3)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: